We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Arthur J. Gallagher & Co
AJG
$62.2B
| $84.8M | 0.11% |
1,086,072
+125,866
| +13% | +$9.7M |
|
202
Vertex Pharmaceuticals
VRTX
$120B
| $84.2M | 0.1% |
457,794
-10,786
| -2% | -$1.99M |
|
203
Korn Ferry
KFY
$3.95B
| $83.9M | 0.1% |
1,872,885
+92,710
| +5% | +$4.24M |
|
204
Zions Bancorporation
ZION
$10.3B
| $83.7M | 0.1% |
1,843,790
+36,655
| +2% | +$1.75M |
|
205
MKS Inc
MKSI
$23.3B
| $83.1M | 0.1% |
893,041
+248,736
| +39% | +$20.1M |
|
|
BRSL
206
Brightstar Lottery PLC
BRSL
$1.92B
| $83M | 0.1% |
6,390,091
+91,298
| +1% | +$1.41M |
|
207
Dominion Energy
D
$62.5B
| $82.4M | 0.1% |
1,075,341
+364,782
| +51% | +$26.6M |
|
|
GMLP
208
DELISTED
Golar LNG Partners LP
GMLP
| $81.2M | 0.1% |
6,292,174
+33,479
| +0.5% | +$438K |
|
209
International Paper
IP
$20.1B
| $81.2M | 0.1% |
1,853,541
+11,392
| +0.6% | +$494K |
|
210
Johnson & Johnson
JNJ
$613B
| $81.1M | 0.1% |
579,800
+354,807
| +158% | +$47.5M |
|
|
XLNX
211
DELISTED
Xilinx Inc
XLNX
| $80.4M | 0.1% |
634,188
-89,338
| -12% | -$10M |
|
212
MacroGenics
MGNX
$273M
| $80.3M | 0.1% |
4,463,410
+16,569
| +0.4% | +$286K |
|
213
AutoNation
AN
$6.85B
| $79.4M | 0.1% |
2,221,927
-75,871
| -3% | -$2.75M |
|
214
ResMed
RMD
$27.9B
| $79.3M | 0.1% |
762,303
+339,632
| +80% | +$35.1M |
|
215
Cedar Fair
FUN
$1.75B
| $78.7M | 0.1% |
1,495,017
-183,644
| -11% | -$9.8M |
|
216
AnaptysBio
ANAB
$1.56B
| $78.6M | 0.1% |
1,075,890
+3,671
| +0.3% | +$253K |
|
217
ConocoPhillips
COP
$145B
| $78.5M | 0.1% |
1,176,072
-180,772
| -13% | -$12.2M |
|
218
Conagra Brands
CAG
$7.05B
| $78M | 0.1% |
2,811,987
-731,097
| -21% | -$16.8M |
|
219
Marathon Petroleum
MPC
$92.7B
| $77.4M | 0.1% |
1,293,424
+274,997
| +27% | +$17.3M |
|
220
HCA Healthcare
HCA
$82.7B
| $76M | 0.09% |
583,194
+217,323
| +59% | +$29.2M |
|
221
SolarEdge
SEDG
$2.94B
| $76M | 0.09% |
2,017,073
-7,240
| -0.4% | -$289K |
|
222
East-West Bancorp
EWBC
$18B
| $76M | 0.09% |
1,583,520
+51,537
| +3% | +$2.63M |
|
|
MRSH
223
Marsh
MRSH
$84.6B
| $74.8M | 0.09% |
796,874
-930,326
| -54% | -$82.3M |
|
224
Etsy
ETSY
$7.61B
| $74.5M | 0.09% |
1,107,730
-111,161
| -9% | -$6.64M |
|
225
Macy's
M
$6.38B
| $73.8M | 0.09% |
3,070,872
+2,937,732
| +2,206% | +$74.2M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.